The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Mybufen Max Rapid 400 mg soft capsules



Bluefish Pharmaceuticals ABPA1436/046/001

Main Information

Trade NameMybufen Max Rapid 400 mg soft capsules
Active SubstancesIbuprofen
Dosage FormCapsule, soft
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/046/001

Group Information

ATC CodeM01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued16/08/2024
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 400 mg, maximum daily dose 1200mg, maximum pack size 25. For use in adults and children not under 12 years.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back